• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Fina Biotech - Product Pipeline Review - H2 2011 Product Image

Fina Biotech - Product Pipeline Review - H2 2011

  • Published: December 2011
  • 28 pages
  • Global Markets Direct

Fina Biotech – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Fina Biotech - Product Pipeline Review - H2 2011” provides data on the Fina Biotech’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Fina Biotech’s corporate website, SEC filings, investor presentations and featured press releases, both from Fina Biotech and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Fina Biotech - Brief Fina Biotech overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Fina Biotech human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules i



List of Tables
List of Figures
Fina Biotech Snapshot
Fina Biotech Overview
Key Information
Key Facts
Fina Biotech – Research and Development Overview
Key Therapeutic Areas
Fina Biotech – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Fina Biotech – Pipeline Products Glance
Fina Biotech Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Fina Biotech – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Fina Biotech – Drug Profiles
Cell Therapy For Stroke
Product Description
Mechanism of Action
R&D Progress
FB 1001
Product Description
Mechanism of Action
R&D Progress
FB 1002
Product Description
Mechanism of Action
R&D Progress
FB 1003
Product Description
Mechanism of Action
R&D Progress
FB 1004
Product Description
Mechani

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS